Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Bio-Rad Laboratories, Inc. Class A Common Stock (NY:BIO)

228.66 -6.09 (-2.59%)
Streaming Delayed Price Updated: 12:10 PM EDT, Apr 4, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Bio-Rad Laboratories, Inc. Class A Common Stock

< Previous 1 2 3 4 Next >
Stocks Head For Weekly Gains, US Treasury Yields Fall Below 4.5%: What's Driving Markets Friday?
Stocks are headed for weekly gains, with the Dow Jones dipping slightly and the S&P 500 and Nasdaq trading just above the flatline Friday. 
Via Benzinga
Topics Stocks
Exposures US Equities
Earnings Scheduled For February 13, 2025
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
The Analyst Verdict: Bio-Rad Laboratories In The Eyes Of 4 Experts
Via Benzinga
Expert Ratings For Bio-Rad Laboratories
Via Benzinga
Triple-Witch Says, “Remember Me?”
Via Talk Markets
The Analyst Landscape: 4 Takes On Bio-Rad Laboratories
Via Benzinga
Bio-Rad Laboratories: Q4 Earnings Insights
Via Benzinga
Palantir Stock Will Join the S&P 500 in September. History Says It Could Soar Afterward.
History says Palantir stock could soar after its inclusion in the S&P 500. 
Via The Motley Fool
Topics Stocks
Exposures US Equities
Palantir Stock Soars After S&P 500 Inclusion, AI Deal With BP Fuels Additional Gains – What's Next?
Palantir (PLTR) stock surges due to inclusion in S&P 500 on Sept. 23 and new enterprise deal with BP. Technicals also show bullish trend. 
Via Benzinga
Topics Artificial Intelligence Stocks
Exposures Artificial Intelligence US Equities
Palantir, Dell Will Join The S&P 500. The AI Stocks Are Jumping.
Palantir, Dell Technologies and Erie Indemnity will join the S&P 500 on Sept. 23. All three stocks jumped late Friday. 
Via Investor's Business Daily
Topics Artificial Intelligence Stocks
Exposures Artificial Intelligence US Equities
S&P 500 Ends First Half Shy Of All-Time Highs. Here Are The Leaders And Laggards — And 5 Stocks That Could Outperform In Next 6 Months
The market's resilient run has made traders cautious of a potential correction, but analysts remain optimistic about its trajectory. 
Via Benzinga
Topics Stocks
Exposures US Equities
Earnings Scheduled For February 15, 2024
Companies Reporting Before The Bell • Cognex (NASDAQ:CGNX) is estimated to report quarterly earnings at $0.10 per share on revenue of $188.59 million. 
Via Benzinga
Preview: Bio-Rad Laboratories's Earnings
Via Benzinga
BIO Stock Earnings: Bio-Rad Laboratories Beats EPS, Misses Revenue for Q1 2024
BIO stock results show that Bio-Rad Laboratories beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024. 
Via InvestorPlace
96% Of S&P 500 Stocks Show Upside Potential Vs. Street Estimates: Which Offers The Best Opportunity?
480 out of 500 S&P 500 companies are trading below analysts' price targets, indicating potential profit opportunities. April has been bleak for the market, but some undervalued stocks may be worth... 
Via Benzinga
Topics Stocks
Exposures US Equities
Tech Stocks Ease On Hot PPI, Yields Rise, Microsoft, Amazon Snap 5-Week Positive Streak: What's Driving Markets Friday?
Wall Street takes pause after stronger-than-expected producer inflation report, potentially delaying Fed rate cuts and impacting major indices and stocks. 
Via Benzinga
Topics Economy
Exposures Interest Rates
Applied Materials Posts Upbeat Earnings, Joins Texas Roadhouse, Vulcan Materials And Other Big Stocks Moving Higher On Friday
U.S. stocks were lower, with the Dow Jones index falling more than 100 points on Friday. 
Via Benzinga
Topics Stocks
Exposures US Equities
Earnings Outlook For Bio-Rad Laboratories
Via Benzinga
10 S&P 500 Stocks With Over 40% Upside Potential: Hidden Gems Or Value Traps?
S&P 500 index surges to new highs, driven by AI, earnings optimism, and Fed rate cuts. Top 10 stocks with significant upside potential for 2024 rally. 
Via Benzinga
Topics Artificial Intelligence Economy Stocks
Exposures Artificial Intelligence Interest Rates US Equities
S&P 500's Hidden Gems: 27 Stocks With 30%+ Upside Potential According To Wall Street Analysts Targets
Fifty-six percent of S&P 500 companies have shown positive performance in 2023 and 44% retreated Moderna Inc. (NASDAQ: MRNA) offers the highest upside potential (58%). 
Via Benzinga
Topics Stocks
Exposures US Equities
Black Friday On Wall Street: 10 S&P 500 Stocks Trading At 40%+ Discount From Analysts' Expectations
Several S&P 500 stocks are trading at discounts of over 40% compared to analysts' price targets, offering potential upside, but caution is needed. 
Via Benzinga
Topics Stocks
Exposures US Equities
The Latest Analyst Ratings for Bio-Rad Laboratories
Via Benzinga
The Latest Analyst Ratings for Bio-Rad Laboratories
Via Benzinga
Why Is Clinical Diagnostic-Focused Bio-Rad Stock Trading Lower Today?
Bio-Rad Laboratories Inc (NYSE: BIO) shares are trading lower after the company lowered its annual revenue growth forecast, citing the uncertain pace of the biopharma sector's recovery and the  
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
3 Beaten-Down Biotech Stocks Bound for a Bounce Back
Biotech stocks are still below their post-pandemic peaks. But these beaten-down biotech stocks could lead the sector to new highs. 
Via InvestorPlace
Why Are velo Biosciences Stock Is Trading Higher Today?
Evelo Biosciences Inc (NASDAQ: EVLO) shares are trading higher after the company terminated its sublease agreement with Bio-Rad Laboratories Inc (NYSE: BIO). 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For June 16, 2023
Via Benzinga
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.